The expression of TLR3 is variable amongst lung cancer cells, prompting us to question the capacity of TLR3 to activate apoptosis and how TLR3 ligands on their own or in combination with other drugs may be administered to treat lung cancer. Here, TLR3 is linked to lung carcinoma.